CMS Bundled Payments

By AHRMM

AHRMM Webinar Image

 

Price: Member: FREE  |  Non-Member: $99.00

CEC Hours: 1

Order Webinar

 

Description:

On July 25, 2016 The Centers for Medicare & Medicaid Services (CMS) issued a proposed ruling which introduces three new episode payment models (EPMs) for Acute Myocardial Infarction (AMI), Coronary Artery Bypass Grafts (CABG), and Surgical Hip/Femur Fracture Treatment (SHFFT). The proposal also included a Cardiac Rehabilitation (CR) incentive payment model and changes to the currently active Comprehensive Care for Joint Replacements (CJR). This webinar provides an overview of the proposed ruling and CJR changes and a discussion of how hospitals should be preparing for the go-live date of July 1, 2017.

 

Learning Objectives:
  • Understand what comprises a Cardiovascular Care (CV) bundle.
  • Relate important changes to CJR that affect your hospitals.
  • Discuss the potential effects of the proposed mandates to your facility.

 

Presenters:
  • April Simon, RN, MSN — Assistant Vice President, HealthTrust
  • Todd Devree — Director of Bundled Payments, HealthTrust

 

This webinar is sponsored by HealthTrust.

HealthTrust Logo

 

Related Resources

Webcast
Part 3 of the GPO or Local/Self Contracting webcast series examines whether compliance can be achieved without alignment, and vice versa.
Webcast
Supply chain is in the unique position, working with so many different disciplines within the hospital, that it is natural that they initiate conve
On-Demand Educational Webinars
Reducing variability in products, supplies, pharmaceuticals, and other cost drivers is key to achieving margins in Medicare payment. This webinar…
Podcasts
A short introduction to the CMS Meaningful Use 3 Rule and how implementing UDI within the healthcare setting and moving toward the full GS1 will re
Webcast
Panelists in Part 4 of the GPO or Local/Self Contracting webcast series focus on what providers should expect from their GPO partners. In a Part 5…
Podcasts
AHRMM Podcast on how supply chain should be interdepartmentally conversing to determine the handling of human-origin medical products and their UDIs.